Cell Harvesting System Market Size, Share & Trends Analysis Report By Type (Manual, Automated) By Application (Umbilical Cord, Bone Marrow, Peripheral Blood), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Cell Harvesting System Market Size & Trends

The global cell harvesting system market size was valued at USD 5.23 billion in 2023 and is projected to grow at a CAGR of 14.4% from 2024 to 2030. The growth of the cell harvesting market includes significant investments in regenerative medicine and expansion of biotechnology and biopharmaceutical sectors. The high prevalence of chronic and infectious diseases, the increasing rate of transplantation, and the demand for stem cell banking are prominent factors that influence market developments.

Moreover, increased demand for healthcare systems owing to chronic illnesses has resulted in robust developments. Another important aspect of the expansion of the cell harvesting systems market is due to growing practices for bone marrow transplantation causing elevated blood cancer and anemia. Emphasis on regenerative medicine and the growing investments in cell-based research add to the market developments. Besides, spending on cryopreservation and automated harvesting boosts productivity. Cell harvesting system procedure enables fewer punctures to minimize the invasiveness of bone marrow partially from the iliac bone. It also helps decrease process time and T-cell contamination. However, a significant hurdle to the cell harvesting industry is the high cost, absence of reimbursement measures, and the identification of stem cells in adult tissues.

Type Insights

The cell harvesting system is segmented into manual and automated systems based on type. The manual cell harvesting systems market segment accounted for the largest share of the total market revenue. Clinical researchers and physicians prefer manual methods mostly for their ease of use, simplicity, and minimal technical expertise. Cost-effectiveness is a key consideration for many healthcare facilities, particularly in developing countries, when opting for manual methods.

Furthermore, the rise of the automated system is also anticipated to be boosted by the growing emphasis on enhancing efficiency and lowering labor costs in healthcare facilities. More uniformity in the quality of harvested cells and a larger cell yield are only a few advantages that automated systems have over manual ones. The demand for automated cell harvesting systems is being pushed by the rising popularity and effectiveness of cell-based therapies, which need many high-quality cells in small amounts.

End-use Insights

In 2023, hospitals dominated the cell harvesting market mainly for spending on storage units and cryogenic preservation techniques. Besides, the research and development conducted by hospitals is also a significant factor for the segment growth. The availability of funding for stem cell projects, and rise in spending on preservation techniques propels the growth of segment.

Research and development in cell harvesting systems experienced significant growth in projected years with a CAGR of 15.1%. The academic institutes and research & development centers are witnessing rapid growth in different aspects such as rising in investments for research by universities and pharmaceutical companies. Moreover, increasing demand for regenerative medication and stem cell-based therapies are further expected to add to the advancement.

Application Insights

Based on application, the peripheral blood segment dominated the market in terms of revenue share of 31.4% in 2023 pertaining to the widespread use of peripheral blood stem cell (PBSC) harvesting driven by its slightly invasive nature and the increasing demand for stem cell treatments. The implementation of cell harvesting systems for extracting stem cells from peripheral blood has risen due to the simplicity of collection and higher stem cell yield compared to alternate sources. This technique has become crucial in hematopoietic stem cell transplantation, a key treatment for various hematological malignancies and disorders.

The adipose tissue witnessed to grow at a CAGR of 16.1% in forthcoming years and the segment growth is highly anticipated. The ease of harvesting and the sufficiency of mesenchymal stem cells in adipose tissue make it a favorable source for regenerative medication applications.

Regional Trends

North America cell harvesting system market accounted for a market share of 39.4% in 2023. The presence of a highly developed medical and healthcare infrastructure fuels a significant share of the cell harvesting market over the forecast period by considering factors such as investments in regenerative medicines, increased biotechnology and biopharmaceutical industry, and the presence of key market players in the region. Canada is relatively following the U.S. and is expected to see considerable growth in the cell harvesting system market due to factors such as urbanization, rising obesity levels, variations in diet, and seamless lifestyle in a fast-paced world-aligned market growth.

U.S. Cell Harvesting System Market Trends

The U.S. cell harvesting system market is dominant with a commanding market share of 87.7% in North America. The rise in disabilities and increasing chronic diseases are prominent causes of mortality. The population is diagnosed with at least one chronic disease and lifestyle-related disorders. Moreover, with the rising cardiovascular diseases and illnesses, the major organizations in cell harvesting play a vital role in treating severe and various types of diseases such as immunodeficiency diseases, cancer, and disorders of hematologic disorders that propels the market growth.

Europe Cell Harvesting System Market Trends

The Europe cell harvesting market is backed by the rising prevalence of clinical diagnostics and procedures. It is increasing, driven by substantial investments in regenerative medicine and enhanced healthcare infrastructure. Various private institutes are actively conducting cutting-edge research and clinical trials for stem-based cells. Moreover, government assistance by funding and regulatory frameworks fuels the market.

Germany cell harvesting systems market is experiencing a rise, driven by various factors such as a focus on biomedical research and development, efficiency, and advancement in healthcare, helps extensive stem cell research initiatives. The growing geriatric population and incidences of chronic illnesses lead to the demand for cell harvesting systems in the country.

Asia Pacific Cell Harvesting System Market Trends

Asia Pacific market for cell harvesting market is anticipated to witnessed significant growth with 15.0% CAGR in the forecast period. Many factors boost the market growth such as the growing demand for stem cell-based therapies and funding for medical research.

Japan cell harvesting system market is likely to capture a large share in the Asia Pacific region during the forecast period. Moreover, Japan is poised to grow due to its huge number of stem cell harvesting centers from bone marrow. Other key factors are urbanization, sedentary lifestyles, changing diets, increasing obesity levels, and the high consumption of tobacco products leading to the development of cancer and cardiac diseases. The capability of stem cells to treat several chronic diseases has added to its popularity. As a result, the cell harvesting market is expected to increase the prevalence of chronic disorders.

China cell harvesting system market holds a huge market share after Japan in the cell harvesting system market. Some key factors include the increase in the elderly population with increasing cardiovascular disorders. Furthermore, the demand has grown in terms of transplantation for stem cell banking which contributes to the harvesting requirements in the country. Besides, the cell harvesting market leverages an overall expansion of the biotechnology sector.

Key Cell Harvesting System Company Insights

Some key companies in the cell harvesting system market include Argos Technologies, Inc.; Perkin Elmer, Inc.; Brand GmBh Co. KG; Arthrex, Inc.; Avita Medical; Tomtec; Terumo Corporation; Teleflex, Inc.; Bertin.; Sartorius AG; in the market is focusing on development & to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives.

• Avita Medical is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns.

• Perkin Elmer Inc. provides laboratory and field services catering to biopharma, food, environmental and safety, and applied end markets. The company offers a portfolio of services including atomic spectroscopy, molecular spectroscopy, chromatography instruments, consumables, and reagents.

Recent Developments

• In March 2024, Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, and CiRA Foundation, a public interest organization for the transfer of induced pluripotent stem (iPS) cells to industry, had a partnership designed to propel the broad use of iPS cells for a range of new therapies. 

• In June 2023, Teleflex Inc., a leading global provider of medical technologies, had a a partnership with Shenzhen Insighters Medical Technology Co., Ltd. as the exclusive U.S. distributor of the Insighters^® Video Laryngoscope system, which is designed for inspecting the upper glottic airway and facilitate endotracheal intubation.

Cell Harvesting System Market Report Scope

Global Cell Harvesting System Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cell harvesting system market report based on type, application, end-use, and region.

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Manual

  • Automated

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Umbilical Cord

  • Bone Marrow

  • Peripheral Blood

  • Adipose Tissue

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospital

  • Clinic

  • Academic Institutes

  • R & D Centers

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • Saudi Arabia

    • UAE

    • South Africa

    • Kuwait